Title: The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
Journal: Expert review of neurotherapeutics 20151001
Title: Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Journal: International journal of clinical practice 20150901
Title: Brexpiprazole: First Global Approval.
Journal: Drugs 20150901
Title: Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.
Journal: The Journal of pharmacology and experimental therapeutics 20140901
Title: Ishima T, et al. Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors. Eur Neuropsychopharmacol. 2015 Apr;25(4):505-11.
Title: Yoshimi N, et al. Improvement of dizocilpine-induced social recognition deficits in mice by brexpiprazole, a novel serotonin-dopamine activity modulator. Eur Neuropsychopharmacol. 2015 Mar;25(3):356-64.
